{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T16:47:21Z","timestamp":1747154841516,"version":"3.40.5"},"reference-count":26,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ajconline.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Cardiology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.amjcard.2018.11.004","type":"journal-article","created":{"date-parts":[[2018,11,24]],"date-time":"2018-11-24T11:00:17Z","timestamp":1543057217000},"page":"690-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Fallacies of Evidence-Based Medicine in Cardiovascular Medicine"],"prefix":"10.1016","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7566-8011","authenticated-orcid":false,"given":"Bernhard","family":"Meier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Nietlispach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjcard.2018.11.004_bib0001","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1001\/jama.1993.03510170083036","article-title":"Users' guides to the medical literature. I. How to get started. The evidence-based medicine working group","volume":"270","author":"Oxman","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0002","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1001\/jama.1993.03510210084032","article-title":"Users' guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-based medicine working group","volume":"270","author":"Guyatt","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0003","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/bmj.312.7023.71","article-title":"Evidence-based medicine: what it is and what it isn't","volume":"312","author":"Sackett","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0004","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J"},{"issue":"Suppl 4","key":"10.1016\/j.amjcard.2018.11.004_bib0005","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1212\/01.wnl.0000277702.74115.9b","article-title":"Evidence-based medicine and clinical trials","volume":"68","author":"Coyle","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0006","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE Guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0007","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/eurheartj\/ehx806","article-title":"Changing definition of hypertension in guidelines: How innocent a number game?","volume":"39","author":"Messerli","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0008","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1093\/eurheartj\/ehw220","article-title":"Interventional cardiology, where real life and science do not necessarily meet","volume":"37","author":"Meier","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0009","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1136\/bmj.327.7429.1459","article-title":"Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials","volume":"327","author":"Smith","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0010","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa1009639","article-title":"Closure or medical therapy for cryptogenic stroke with patent foramen ovale","volume":"366","author":"Furlan","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0011","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1056\/NEJMoa1211716","article-title":"Percutaneous closure of patent foramen ovale in cryptogenic embolism","volume":"368","author":"Meier","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0012","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1056\/NEJMoa1301440","article-title":"Closure of patent foramen ovale versus medical therapy after cryptogenic stroke","volume":"368","author":"Carroll","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0013","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/ccd.21651","article-title":"Closure of the patent foramen ovale with dedicated Amplatzer occluders: closing in on a mechanical vaccination","volume":"72","author":"Meier","year":"2008","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0014","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/j.amjcard.2014.08.027","article-title":"Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale","volume":"114","author":"Pickett","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa1610057","article-title":"Long-term outcomes of patent foramen ovale closure or medical therapy after stroke","volume":"377","author":"Saver","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0016","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1056\/NEJMoa1705915","article-title":"Patent foramen ovale closure or anticoagulation vs. antiplatelets after stroke","volume":"377","author":"Mas","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0017","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1056\/NEJMoa1707404","article-title":"Patent foramen cvale closure or antiplatelet therapy for cryptogenic stroke","volume":"377","author":"Sondergaard","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0018","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/CIRCULATIONAHA.107.727271","volume":"117","author":"Dowson","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0019","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1093\/eurheartj\/ehw027","article-title":"Percutaneous closure of patent foramen ovale in migraine with aura, a randomized conrolled trial","volume":"37","author":"Mattle","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0020","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1016\/j.jacc.2017.09.1105","article-title":"Percutaneous closure of patent foramen ovale in patients with migraine: the PREMIUM trial","volume":"70","author":"Tobis","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0021","first-page":"354","article-title":"Patent foramen ovele, good reasons to close it","volume":"43","author":"Meier","year":"2018","journal-title":"Deutsche Med Wochenschr"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0022","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(17)32714-9","article-title":"Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial","volume":"391","author":"Al-Lamee","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0023","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4414\/cvm.2018.00541","article-title":"Stents bei angina pectoris: wie wirksam sind sie wirklich?","volume":"21","author":"Luescher","year":"2018","journal-title":"Cardiovasc Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0024","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0140-6736(17)32757-5","article-title":"Last nail in the coffin for PCI in stable angina?","volume":"391","author":"Brown","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0025","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1056\/NEJMe1208620","article-title":"Which is more enduring - FAME or COURAGE?","volume":"367","author":"Boden","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjcard.2018.11.004_bib0026","doi-asserted-by":"crossref","first-page":"g3859","DOI":"10.1136\/bmj.g3859","article-title":"Revascularisation versus medical treatment in patients with stable coronary artery disease: network meta-analysis","volume":"348","author":"Windecker","year":"2014","journal-title":"BMJ"}],"container-title":["The American Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491832085X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000291491832085X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T20:47:07Z","timestamp":1548362827000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000291491832085X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":26,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S000291491832085X"],"URL":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.004","relation":{},"ISSN":["0002-9149"],"issn-type":[{"type":"print","value":"0002-9149"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fallacies of Evidence-Based Medicine in Cardiovascular Medicine","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjcard.2018.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}